PROMO!
First order? Get 10% OFF with this code: 1storder
PROMO!
First order? Get 10% OFF with this code: 1storder
Our Product Categories
The 5-Amino-1MQ peptide is a small molecule that researchers are studying for its potential role in weight management. It functions by blocking an enzyme known as nicotinamide N-methyltransferase (NNMT), which is important for how the body stores fat and uses energy. By blocking NNMT, 5-Amino-1MQ may help the body burn more energy, encourage fat loss, and improve metabolism. While early research looks promising for treating obesity, more clinical trials are necessary to confirm its long-term safety and effectiveness.
Peptide Sequence (IUPAC Condensed): 1-methylquinolin-1-ium-5-amine
Molecular Formula: C10H11N2+
Molecular Weight: 159.21 g/mol
Synonyms: 5-amino-1-methylquinolinium
5-Amino-1MQ is a selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme essential for regulating nicotinamide metabolism and energy balance. NNMT transfers methyl groups from S-adenosylmethionine (SAM) to nicotinamide, generating 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine (SAH). This reaction can reduce cellular levels of nicotinamide adenine dinucleotide (NAD+), a key coenzyme in mitochondrial energy production, redox reactions, and metabolic processes.
By inhibiting the NNMT enzyme, 5-Amino-1MQ helps maintain NAD+ levels within cells. Higher NAD+ availability supports mitochondrial function, boosts energy expenditure, and improves fatty acid oxidation. This process also encourages lipolysis (the breakdown of fats), which can lead to less fat accumulation and improved body composition. Mouse studies have shown that blocking NNMT with 5-Amino-1MQ offers significant metabolic benefits, including reduced body fat, better insulin sensitivity, and higher energy production. This makes NNMT a promising target for treating metabolic conditions like obesity and insulin resistance.
Reduces Fat Build-Up: Research suggests that 5-amino-1MQ has shown promise in early studies for promoting fat loss by altering how the body uses energy. NNMT has been increasingly associated with obesity and type 2 diabetes, which are linked to disruptions in energy storage and lipid metabolism (1).
Knockdown of NNMT has been shown to increase energy expenditure in adipose and hepatic tissues, reduce lipid accumulation, and improve insulin sensitivity (2). Together, these findings support NNMT as a possible treatment target. Nonetheless, despite these promising lab and animal results, the exact processes are not fully understood, and testing in humans is still needed.
Improves Metabolism: Early studies suggest that 5-Amino-1MQ may help metabolism by blocking NNMT, an enzyme that controls energy use and fat storage. Higher NNMT activity is linked to obesity and metabolic problems, while blocking NNMT has been shown to boost cell energy use, improve mitochondrial function, and lower fat in animal studies (3). Research also shows that blocking NNMT may improve metabolism without changing how much animals eat, which suggests the benefits come from better energy use, not just less appetite (4).
Increases NAD⁺ levels (cellular energy support): 5-Amino-1MQ may help preserve intracellular NAD⁺ levels by blocking NNMT-mediated depletion of nicotinamide, a key precursor required for NAD⁺ synthesis. NAD⁺ is essential for mitochondrial function, cellular repair, and energy production. Studies involving NNMT inhibition have demonstrated increased NAD⁺ availability and activation of metabolic pathways associated with improved cellular energy regulation and mitochondrial efficiency (5). Because declining NAD⁺ levels are associated with aging and metabolic disease, maintaining NAD⁺ availability has become an important area of longevity and metabolic research (6).
Potential Anti-Aging Effects: While there is no human data yet, researchers think 5-Amino-1MQ might help with aging because of its effects on NAD⁺ and cell energy. More NAD⁺ may support sirtuins, proteins that help repair DNA, keep mitochondria healthy, and support aging well (6). Early studies suggest that blocking NNMT could slow age-related metabolic decline and make cells stronger in lab models, but these results have not been proven in people (5,6).
Possible Improvement in Insulin Sensitivity: Preclinical research suggests that 5-Amino-1MQ may influence insulin sensitivity and glucose metabolism by inhibiting the nicotinamide N-methyltransferase (NNMT) enzyme. Elevated NNMT activity has been associated with insulin resistance and impaired glucose handling, while genetic or pharmacological inhibition of NNMT has been shown to improve insulin sensitivity in animal models.
For example, studies have demonstrated that reducing NNMT activity enhances metabolic health and protects against diet-induced insulin resistance (7). Similarly, small-molecule NNMT inhibitors, including 5-Amino-1MQ, have been shown to improve metabolic parameters in mice (8). These effects are thought to be mediated by increased NAD⁺ availability and improved cellular energy regulation; however, such benefits have not yet been confirmed in human clinical studies.
(1) Liu, J., Deng, Z., Zhu, X., Zeng, Y., Guan, X. & Li, J. (2021). Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes. BioMed Research International. https://doi.org/10.1155/2021/9924314
(2) Xu, W., Hou, L., Li, P. & Li, L. (2022). Effect of nicotinamide N-methyltransferase on lipid accumulation in 3T3-L1 adipocytes. Bioengineered 13(5), pp. 12421-12434. https://doi.org/10.1080/21655979.2022.2074768
(3) Hong S, Moreno-Navarrete JM, Wei X, Kikukawa Y, Tzameli I, Prasad D, Lee Y, Asara JM, Fernandez-Real JM, Maratos-Flier E, Pissios P. Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. Nat Med. 2015 Aug;21(8):887-94. doi: 10.1038/nm.3882. Epub 2015 Jul 13. PMID: 26168293; PMCID: PMC4529375.
(4) Neelakantan H, Vance V, Wetzel MD, Wang HL, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochem Pharmacol. 2018 Jan;147:141-152. doi: 10.1016/j.bcp.2017.11.007. Epub 2017 Nov 15. PMID: 29155147; PMCID: PMC5826726.
(5) Bonkowski MS, Sinclair DA. Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds. Nat Rev Mol Cell Biol. 2016 Nov;17(11):679-690. doi: 10.1038/nrm.2016.93. Epub 2016 Aug 24. PMID: 27552971; PMCID: PMC5107309.
(6) Ole Kristian Reiten, Martin Andreas Wilvang, Sarah J. Mitchell, Zeping Hu, Evandro F. Fang, Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing, Mechanisms of Ageing and Development, Volume 199,
2021, 111567.
(7) Kraus D, Yang Q, Kong D, Banks AS, Zhang L, Rodgers JT, Pirinen E, Pulinilkunnil TC, Gong F, Wang YC, Cen Y, Sauve AA, Asara JM, Peroni OD, Monia BP, Bhanot S, Alhonen L, Puigserver P, Kahn BB. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014 Apr 10;508(7495):258-62.
(8) Neelakantan H, Vance V, Wetzel MD, Wang HL, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochem Pharmacol. 2018 Jan;147:141-152.
The answers to the most frequently asked questions about the peptide.
Research suggests that blocking NNMT may help keep more nicotinamide available, which is needed to make NAD⁺. NAD⁺ is important for energy, cell repair, and healthy mitochondria. Keeping NAD⁺ levels up is a key goal in longevity and metabolic research.
Research on 5-Amino-1MQ is still limited, and human studies are lacking. Reported side effects are generally mild and may include headaches, nausea, trouble sleeping, or temporary jitteriness. Animal studies suggest it is well tolerated, but the long-term safety in humans is still unknown.
It is legal to buy 5-Amino-1MQ for research, however, it is not approved by the FDA for the treatment, prevention, or cure of any disease. Research remains ongoing, and the compound is considered investigational.
Early research suggests that lowering NNMT activity may help with insulin sensitivity and how the body handles glucose. These effects have been seen in animal studies, but more human research is needed before we can be sure.
NNMT is also called nicotinamide N-methyltransferase. It is an enzyme involved in how the body manages energy and certain metabolic processes. Increased NNMT activity has been linked to obesity, insulin resistance, and other metabolic issues. As a result, it has become an important area of research in metabolism, weight management, and healthy aging.
NAD⁺ peptides are designed to raise NAD⁺ levels, either by providing NAD⁺ itself or by supplying building blocks like NMN or NR that the body can use to make more NAD⁺. On the other hand, 5-Amino-1MQ takes a different approach: it blocks an enzyme called NNMT. Doing this helps keep more nicotinamide available, which your body needs to make NAD⁺ naturally. So, while both aim to support NAD⁺, they work through distinct pathways.
This blog explores whether 5-Amino-1MQ can enhance mental clarity, energy, and focus by working at the cellular level. Unlike traditional cognitive peptides such as Selank and Semax, which primarily target brain signalling and neurotransmitters, 5-Amino-1MQ focuses on foundational cellular energy. By inhibiting the NNMT enzyme, it significantly boosts the availability of nicotinamide, directly supporting vital NAD+ and ATP production inside the mitochondria. This enhanced energy generation powers brain cells, offering a unique, metabolism-first approach to combating mental fatigue. Ultimately, the research highlights 5-Amino-1MQ as a promising compound for naturally supporting sustained mental drive and sharper cognitive focus.
This blog explores whether 5-Amino-1MQ effectively targets hard-to-lose visceral fat by acting on cellular energy pathways. It highlights how 5-Amino-1MQ inhibits the NNMT enzyme, which preserves vital NAD+ levels. This process improves metabolic efficiency and shifts the body towards using energy rather than storing it as deep abdominal fat. Furthermore, the article compares 5-Amino-1MQ to Tesamorelin. It notes that while 5-Amino-1MQ regulates internal fat tissue metabolism, Tesamorelin directly reduces visceral fat through growth hormone signalling. Ultimately, research reveals both peptides offer promising, targeted approaches to improving fat distribution, cellular energy regulation, and overall metabolic health.
This blog explores how NAD+ supplements help support cellular energy and why NAD+ is important for mitochondria, metabolism, and overall health. It covers how cells make ATP, the main energy source, and how lower NAD+ levels can affect energy and recovery. The article also looks at research compounds like Tesofensine, Sermorelin, and 5-Amino-1MQ, showing their different roles in metabolism, energy use, cell repair, and NAD+ regulation. These compounds highlight the growing interest in energy support, metabolic health, and cell performance research.
Excellent Customer Support
Value For Money
99% Pure Guaranteed
World Wide Shipping
ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.
DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for {name} research development and laboratory studies. The information available on our Peptide Works website: https://peptide-works.com/ is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.
